Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Gross Margin: 2010-2018

Historic Gross Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -650.21%.

  • EyePoint Pharmaceuticals' Gross Margin fell 75021.00% to -650.21% in Q3 2018 from the same period last year, while for Sep 2018 it was -63.57%, marking a year-over-year decrease of 16357.00%. This contributed to the annual value of 48.94% for FY2018, which is 5106.00% down from last year.
  • According to the latest figures from Q3 2018, EyePoint Pharmaceuticals' Gross Margin is -650.21%, which was down 750.21% from 100.00% recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Gross Margin registered a high of 100.00% during Q1 2014, and its lowest value of -650.21% during Q3 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Gross Margin averaged around 31.80%, with its median value being 100.00% (2018).
  • Data for EyePoint Pharmaceuticals' Gross Margin shows a maximum YoY tumbled of 75,021bps (in 2018) over the last 5 years.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Gross Margin stood at 100.00% in 2014, then remained steady at 100.00% in 2015, then remained steady at 100.00% in 2016, then remained steady at 100.00% in 2017, then crashed by 75,021bps to -650.21% in 2018.
  • Its last three reported values are -650.21% in Q3 2018, 100.00% for Q2 2018, and 100.00% during Q1 2018.